About biotechnology application, Biotech Summit Advisory Board

Sports / Entertainment



Small Cast Stars in China Reverse Mergers 0

Posted on December 26, 2010 by admin

Small Cast Stars in China Reverse Mergers
Updates to clarify role of Asensio.com. BOSTON (TheStreet) — Putting together the reverse mergers that bring Chinese companies to U.S. stock exchanges requires a lot of specialized expertise and connections, so the deals tend to get done in a small world where many of the same players work together on deal after deal. It’s such a small world that relationships and connections can generate …

Read more on TheStreet.com

Research and Markets: Pharmaceutical Mergers & Acquisitions – M&A in the Biopharmaceutical Industry and the Impact on … 0

Posted on November 11, 2010 by admin

Research and Markets: Pharmaceutical Mergers & Acquisitions – M&A in the Biopharmaceutical Industry and the Impact on …
Research and Markets has announced the addition of the “Pharmaceutical Mergers & Acquisitions – M&A in the Biopharmaceutical Industry and the Impact on Innovation” report to their offering.

Read more on Business Wire via Yahoo! Finance

Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.: An article from: San Diego Business Journal 0

Posted on August 12, 2010 by admin

Product Description
This digital document is an article from San Diego Business Journal, published by Thomson Gale on July 16, 2007. The length of the article is 1001 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.
Author: Katie Weeks
Publication: San Diego Business Journal (Magazine/Journal)
Date: July 16, 2007
Publisher: Thomson Gale
Volume: 28 Issue: 29 Page: 1(2)

Distributed by Thomson Gale

Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.: An article from: San Diego Business Journal



↑ Top

Powered by Yahoo! Answers